Navigation Links
Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer
Date:9/26/2011

/a>.

About Ipsen

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.1 billion in 2010. Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology / Dysport®, endocrinology / Somatuline®, uro-oncology / Decapeptyl® and hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient-driven platforms, peptides and toxins. In 2010, R&D expenditure totaled more than €220 million, above 20% of Group sales. The Group has total worldwide staff of close to 4,500 employees. Ipsen's shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the "Service de Règlement Différé" ("SRD"). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the over-the-counter market in the United States under the symbol IPSEY. For more information on Ipsen, visit http://www.ipsen.com.

References

  1. Jichlinski P et al. J Urol 2003; 170: 226-9
  2. Stenzl. J Urol, 2010; 184: 1907-1914
  3. Jichlinski P et al. J Urol 2003; 170: 226-9
  4. Jocham D et al. J Urol 2005; 174: 862-6
  5. Stenzl A et al. J Urol 2010; 184: 1907-1914


For further information, please contact:

Photocure
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535, Email: kh@photocure.no

CFO Christian Fekete
Tel: + 47 916 42 938, Email: cf@photocure.no

M: Communications

Mary Clark, Amber Bielecka
Tel: +44 207920 2361, Email:

SOURCE Photocure ASA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of ... D 2015 enrollment data shows that 81 percent of ... access and extra discounts at certain pharmacies. The findings ... "Preferred pharmacy plans are now the foundation of Medicare ...
(Date:1/23/2015)... and DUBLIN , Jan. 23, ... agreement with KRS Global Biotechnology, Inc. for the compounding, packaging ... compounded for shipment in the United States ... approved Outsourcing Facility capable of compounding naltrexone tablets in various ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Jan. 10, 2011 Watson Pharmaceuticals, Inc. (NYSE: ... Investor Day on January 21, 2011 in New York City. ... Time and will be simultaneously webcast. At ... for 2011. The presenters will include: Paul Bisaro, Watson,s President ...
... Inc., a privately held, medical device company, today announced ... Annual Healthcare Conference to be held January 10 -13, ... Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20090409/SF96872LOGO ) ... Wyles, President and CEO, will provide a corporate overview, ...
Cached Medicine Technology:
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... 23, 2015 Recently, Weddingshe.com has added many ... has announced its highest annual revenues in the past three ... popular glamorous wedding dresses. , According to the sales manager ... dress promotions for them in 2015. This point can be ...
(Date:1/22/2015)... As interest in the value of spiritual support as ... Rev. Eric J. Hall , president and CEO of the ... the keynote speaker on January 27 at an international summit ... The conference, “Hope and Resilience: Innovative and Interdisciplinary Spiritual Care,” ...
(Date:1/22/2015)... January 22, 2015 State Forestry Institute ... management system with support from GEOSYSTEMS, a dedicated Hexagon ... solution will leverage Hexagon Geospatial’s ERDAS APOLLO ... as well as point clouds and documents. This effort ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... 8 The Bowen,Foundation,s inaugural ,Cruise to Cure ... the first of the foundation,s events planned to ... a child diagnosed,with autism. The foundation, which was ... old son Bowen was diagnosed with autism three ...
... (Unaudited) ... For the three months ended For the six months ended ... 2007 2006 ... $3,069,762 $2,315,781 $7,940,405 $7,836,896, Gross profit ...
... ANGELES, Nov. 8 Response Genetics, Inc.,(Nasdaq: ... of molecular,diagnostic tests for cancer, today announced it ... results in a press release on,Wednesday, November 14, ... Genetics, Inc. ("RGI") is engaged in the research ...
... Texas, Nov. 9 - then in Chicago, LA and D.C., ... military and vets,since World War I, NEW HAVEN, Conn., Nov. ... million worth of wheelchairs to,veterans in need at four VA Hospital ... history of K of C service to the men and,women of ...
... --(GLENVIEW, Ill.) Representing the interests of pain patients in ... and former President of the American Academy of Pain Medicine ... Policy Act of 2007. , The crisis ... for those who suffer. It is now a social ...
... Introducing SharpGuard(TM) Microsurgical Guarded Knives For Use In ... ... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... it plans to exhibit its,SharpGuard(TM) product line as well as ...
Cached Medicine News:Health News:Inaugural Annapolis Autism Fundraiser Raises $30,000 and Offers Hope and Support for Local Communities 2Health News:MagStar Technologies, Inc. Announces Third Quarter 2007 Results 2Health News:MagStar Technologies, Inc. Announces Third Quarter 2007 Results 3Health News:Response Genetics to Announce Third Quarter 2007 Financial Results on Wednesday, November 14, 2007 2Health News:Knights to Distribute $1 Million Worth of Wheelchairs for Veterans 2Health News:National physician organization supports Capps-Rogers Bill at today's congressional briefing 2Health News:Angiotech To Participate In The American Academy Of Ophthalmology (AAO) 2007 Annual Meeting 2
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests and ... for the following environments: industry, education, ... care and office. • With tubular ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTT/1P chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With tubular ...
Medicine Products: